The CDC said Thursday that the mutations, detected in a sample taken from a Louisiana patient, may help bind the virus to the ...

In STAT's "jealousy list" for 2024, STAT staffers explain what makes a selection of stories they read in other publications ...

Here we are, on the cusp of the midway point in a decade that has been, in global health and infectious diseases terms, a lot ...

STAT '3 to Watch' series looks at biotech industry issues in 2025: Trump administration uncertainties, pharma deals in China, ...

Whether the next pandemic is caused by H5N1 bird flu or something else, we must prepare now to use convalescent plasma to ...

Retractions are meant to maintain trust in science — but on social media, they're often used to reinforce anti-science bias ...

One of those experts was Stanley Biber, a pioneer of vaginoplasties in the U.S. and perhaps the country’s busiest ...

Bone marrow transplants, long a mainstay of blood cancer treatments, are becoming less common in favor of options like CAR-T ...

The “skin in the game” experiment has failed to achieve its primary raison d’être. Over the past two decades, it has not ...

Although research and development funding for tuberculosis reached new heights last year, the total fell substantially short of goals set by the United Nations and most of the increase came from ...

U.S. senators and other lawmakers argue the problems created by UnitedHealth's size and reach demand steps to restore public ...

The killing of UnitedHealthcare CEO Brian Thompson has sparked extraordinary public interest in the nation’s health insurance ...